New Jersey Administrative Code
Title 8 - HEALTH
Chapter 21 - FOOD AND DRUGS
Subchapter 4 - NEW DRUGS
Section 8:21-4.1 - Statement of policy

Universal Citation: NJ Admin Code 8:21-4.1

Current through Register Vol. 56, No. 18, September 16, 2024

(a) The following "new drug" regulations as adopted by the Department of Health (Department) are to provide guidance in the administration of the provisions of N.J.S.A. 24:6A-1 et seq.

(b) To ensure that a complete and comprehensive review for safety is provided to a new drug application submitted pursuant to the State act, it has been deemed proper and expeditious to adopt by reference such procedures, records, reports, sampling, toxicology, pathology, and clinical testing measures afforded to new drugs by the United States Food and Drug Administration as provided in 21 C.F.R. 300, 310, 312, and 314.

(c) It is the intent and policy of the Department to implement and administer those provisions of the Federal new drug regulations adopted by this Department that pertain to or are concerned with the safety of the product subject of a State new drug application.

Disclaimer: These regulations may not be the most recent version. New Jersey may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.